Castleman disease and associated autoimmune disease

Theresa W. Muskardina, Bruce A. Peterson, Jerry A. Molitor

Research output: Contribution to journalReview article

42 Scopus citations

Abstract

Advances in understanding of pathogenic cell types and cytokines in Castleman disease have allowed the development of targeted therapies successful in the treatment of both Castleman disease and associated autoimmune disease.

Original languageEnglish (US)
Pages (from-to)76-83
Number of pages8
JournalCurrent Opinion in Rheumatology
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2012

    Fingerprint

Keywords

  • B-lymphocyte
  • Castleman disease
  • Innate immunity
  • Interferon
  • Interleukin-6
  • Plasmacytoid dendritic cell

Cite this